Evexia Diagnostics Partners with Genomind to Offer Cutting-Edge Pharmacogenetic Testing to Clinicians
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.
Genomind Launches First-of-Its-Kind Patient Report: Offering Patients an Easy-to-Understand View into Personalized Genetic Test Results
KING OF PRUSSIA, Pa.–(BUSINESSWIRE)–Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient Report. This new report empowers patients with easy-to-understand insights about how their genetics influence their body’s response to many medications. By making this information more accessible, the report fosters better […]
Genomind is Advancing how Healthcare Providers Prescribe Medications Better, Faster – Expanding Beyond Mental Health
Genomind is expanding its genetic panel and introducing a new streamlined report with actionable insights for patients – the Express Report
Genomind Pharmacogenetic Population Health Tool Highlighted in American Journal of Managed Care and 22nd Population Health Colloquium
Innovative approach addresses a huge and costly public health burden.
Genomind Launches GenMed Pro™ Precision Gene-Drug Interaction Software to Revolutionize the Prescription Process
Genomind®, the leader in comprehensive genetics and digital mental health services, has announced the launch of GenMed✔ Pro™ – Precision Gene-Drug Interaction Software.
Genomind Announces Major Industry-Leading HLA-A Test Innovation on its Comprehensive Mental Health Pharmacogenetics (PGx) Test, Increasing Utility for Tens of Thousands of Clinicians and Patients
Genomind Announces Major Industry-Leading HLA-A Test Innovation on its Comprehensive Mental Health Pharmacogenetics (PGx) Test.
Genomind Releases Mental Health Map Consumer DNA Test
A breakthrough in the translation of genetic mechanisms and traits that can influence a person’s behavioral predispositions
Genomind Launches Express Ship-to-Patient Capability for Genomind Professional PGx Express Test Enabling Access to Critical Mental Health Treatment Information
Genomind becomes the first company to offer direct-to-patient, at-home mental health pharmacogenetic testing.
Genomind Expands Mental Health Genetic Testing Services with New Genomind Professional PGx Express
Genomind launches Genomind Professional PGx Express™, a new, more focused report and set of services to enhance its mental health genetic testing.
Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions
Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions.
Mindful DNA® Professional, Genetic Testing for Personalized Wellness, Forms Wellness Advisory Board of Medical and Research Leaders
Mindful DNA® Professional, Genetic Testing for Personalized Wellness, Forms Wellness Advisory Board of Medical and Research Leaders.
A Breakthrough in Personalized Wellness: Mindful DNA® Professional Genetic Testing
Genomind launches Mindful DNA to healthcare providers looking for genetic guidance on lifestyle, diet, and/or nutritional supplement decisions.
Genomind Patient Gateway Launches as an Easy Way to Access Patient Education and Track Health
Genomind® Patient Gateway Launches as an Easy Way to Access Patient Education and Track Health.
Clinicians Gain Powerful New Tool When Treating Patients For Mental Illness: G-DIG, Exclusively From Genomind, Enhances Personalized Medicine
Clinicians Gain Powerful New Tool When Treating Patients For Mental Illness: G-DIG, Exclusively From Genomind, Enhances Personalized Medicine.
Genetic Testing for ADHD Patients From Genomind Can Help Them Get Better
Summer is ideal to diagnose and treat ADHD. Clinicians who use Genomind’s Genecept Assay® say testing young patients when they aren’t in school makes sense.
Clinicians and Patients Gain Powerful Advanced Test for Mental Health as the Genecept Assay Builds on Existing Patient Success
Genomind has expanded its existing panel to 18 total genes based on the critical examination of hundreds of published studies showing that variations in these genes can inform treatment decisions in p
Genomind Clinical Study Demonstrates effectiveness of the Genecept™ Assay
Genomind Clinical Study Demonstrates effectiveness of the Genecept™ Assay
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay At NEI Global Psychopharmacology Congress
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay At NEI Global Psychopharmacology Congress
Genomind Presents New Data Supporting Use Of The Genecept™ Assay At ISCTM
Genomind Presents New Data Supporting Use Of The Genecept™ Assay At ISCTM
Genomind Launches New Clinician Portal
Genomind Launches New Clinician Portal
Genomind Announces New Portal At NEI Global Psychopharmacology Congress
Genomind Announces New Portal At NEI Global Psychopharmacology Congress
Enhanced Biomarker Test Aids Clinicians With Difficult To Treat Psychiatric Patients
Enhanced Biomarker Test Aids Clinicians With Difficult To Treat Psychiatric Patients
Genecept Assay Increases Clinician Confidence In Treatment Decisions
Genecept Assay Increases Clinician Confidence In Treatment Decisions
DNA Genotek’s Sample Collection Kit Selected By Genomind For Personalized Medicine Test
DNA Genotek’s Sample Collection Kit Selected By Genomind For Personalized Medicine Test
